Clinical Trials Logo
  1. Home
  2. Metabolic Syndrome
  3. NCT04123132
  4. Details
NCT04123132 Clinical Trial

Evaluation of Kinesophobia in Patients With Metabolic Syndrome

Metabolic Syndrome Clinical Trial

Official title:
Evaluation of Kinesophobia in Patients With Metabolic Syndrome

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04123132
Other study ID # 08090081DEB
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 25, 2019
Est. completion date February 1, 2020

Study information
Verified date January 2020
Source Erol Olcok Corum Training and Research Hospital
Contact Dilek E Büyüksireci
Phone +905439196253
Email dilekeker55@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Metabolic syndrome (MS) is a public health problem characterized by central obesity, increased blood pressure and triglyceride levels, decreased blood HDL levels and the presence of insulin resistance (1).Kinesiophobia is a fear of irrational movement that develops because of its belief in susceptibility to injury and is associated with low levels of physical activity. Considering that exercise improves metabolic processes in people with MS, we aimed to evaluate the presence of kinesophobia in patients with MS.

Patients aged 45-65 years diagnosed with metabolic syndrome and healthy controls will be included in the study. Patients with rheumatic and neurological diseases,history of trauma, gonarthrosis, lumbar disc hernia, previous fractures, fibromyalgia and those who have experienced pain for the last week will be excluded. The participants will be filled in the Short Form-36 (SF-36), the Hospital Anxiety and Depression Scale, and the Tampa Kinesiophobia Scale. 48 patients with MS and 48 healthy participants will be included in the study.

Recruitment information / eligibility
Status Recruiting
Enrollment 96
Est. completion date February 1, 2020
Est. primary completion date February 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 45 Years to 65 Years
Eligibility Inclusion Criteria:

- Patients with metabolic syndrome

Exclusion Criteria:

- Patients with rheumatic disease

- Patients with neurologic disease

- Patients with history of trauma

- Patients with gonartrosis

- Pateints with fibromialgia

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Kinesiophobia
The presence of kinesiofobia in patients with metabolic syndrome

Locations
Country Name City State
Turkey Dilek Eker Büyüksireci Çorum Central Anatolia

Sponsors (1)
Lead Sponsor Collaborator
Erol Olcok Corum Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome
Type Measure Description Time frame Safety issue
Primary Tampa Kinesiophobia Scale People takes between 17-68 total a score. The score of the person shows high kinesiophobia on the scale 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT04635202 - Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome N/A
Completed NCT05343858 - Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome N/A
Completed NCT04053686 - An Intervention to Reduce Prolonged Sitting in Police Staff N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Recruiting NCT05040958 - Carotid Atherosclerotic Plaque Load and Neck Circumference
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Active, not recruiting NCT02500147 - Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) Phase 4
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Completed NCT03289897 - Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan N/A
Recruiting NCT05956886 - Sleep Chatbot Intervention for Emerging Black/African American Adults N/A
Completed NCT06057896 - Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
Active, not recruiting NCT03613740 - Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion Phase 2
Completed NCT04498455 - Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency Phase 4
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT03697382 - Effect of Daily Steps on Fat Metabolism N/A
Completed NCT03241121 - Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome N/A
Completed NCT04509206 - Virtual Teaching Kitchen N/A
Completed NCT05124847 - TREating Pediatric Obesity N/A